Literature DB >> 23651890

Surgical site infections, International Nosocomial Infection Control Consortium (INICC) report, data summary of 30 countries, 2005-2010.

Victor D Rosenthal1, Rosana Richtmann, Sanjeev Singh, Anucha Apisarnthanarak, Andrzej Kübler, Nguyen Viet-Hung, Fernando M Ramírez-Wong, Jorge H Portillo-Gallo, Jessica Toscani, Achilleas Gikas, Lourdes Dueñas, Amani El-Kholy, Sameeh Ghazal, Dale Fisher, Zan Mitrev, May Osman Gamar-Elanbya, Souha S Kanj, Yolanda Arreza-Galapia, Hakan Leblebicioglu, Soňa Hlinková, Badaruddin A Memon, Humberto Guanche-Garcell, Vaidotas Gurskis, Carlos Alvarez-Moreno, Amina Barkat, Nepomuceno Mejía, Magda Rojas-Bonilla, Goran Ristic, Lul Raka, Cheong Yuet-Meng.   

Abstract

OBJECTIVE: To report the results of a surveillance study on surgical site infections (SSIs) conducted by the International Nosocomial Infection Control Consortium (INICC).
DESIGN: Cohort prospective multinational multicenter surveillance study.
SETTING: Eighty-two hospitals of 66 cities in 30 countries (Argentina, Brazil, Colombia, Cuba, Dominican Republic, Egypt, Greece, India, Kosovo, Lebanon, Lithuania, Macedonia, Malaysia, Mexico, Morocco, Pakistan, Panama, Peru, Philippines, Poland, Salvador, Saudi Arabia, Serbia, Singapore, Slovakia, Sudan, Thailand, Turkey, Uruguay, and Vietnam) from 4 continents (America, Asia, Africa, and Europe). PATIENTS: Patients undergoing surgical procedures (SPs) from January 2005 to December 2010.
METHODS: Data were gathered and recorded from patients hospitalized in INICC member hospitals by using the methods and definitions of the Centers for Disease Control and Prevention National Healthcare Safety Network (CDC-NHSN) for SSI. SPs were classified into 31 types according to International Classification of Diseases, Ninth Revision, criteria.
RESULTS: We gathered data from 7,523 SSIs associated with 260,973 SPs. SSI rates were significantly higher for most SPs in INICC hospitals compared with CDC-NHSN data, including the rates of SSI after hip prosthesis (2.6% vs. 1.3%; relative risk [RR], 2.06 [95% confidence interval (CI), 1.8-2.4]; P < .001), coronary bypass with chest and donor incision (4.5% vs. 2.9%; RR, 1.52 [95% CI, 1.4-1.6]; [P < .001); abdominal hysterectomy (2.7% vs. 1.6%; RR, 1.66 [95% CI, 1.4-2.0]; P < .001); exploratory abdominal surgery (4.1% vs. 2.0%; RR, 2.05 [95% CI, 1.6-2.6]; P < .001); ventricular shunt, 12.9% vs. 5.6% (RR, 2.3 [95% CI, 1.9-2.6]; P < .001, and others.
CONCLUSIONS: SSI rates were higher for most SPs in INICC hospitals compared with CDC-NHSN data.

Entities:  

Mesh:

Year:  2013        PMID: 23651890     DOI: 10.1086/670626

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  26 in total

1.  Use of surveillance data to identify target populations for Staphylococcus aureus vaccines and prevent surgical site infections: a pilot study.

Authors:  Marie-Paule Gustin; Marine Giard; Thomas Bénet; Philippe Vanhems
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

Review 2.  Antibiotic use and emerging resistance: how can resource-limited countries turn the tide?

Authors:  Lisa M Bebell; Anthony N Muiru
Journal:  Glob Heart       Date:  2014-10-31

3.  Incidence and Etiology of Surgical Site Infections in Appendectomies: A 3-Year Prospective Study.

Authors:  Humberto Guanche Garcell; Ariadna Villanueva Arias; Cristobal A Pancorbo Sandoval; Elias Guilarte García; Moraima E Valle Gamboa; Adam Bode Sado; Ramón N Alfonso Serrano
Journal:  Oman Med J       Date:  2017-01

4.  Clinical Implication of Diabetes Mellitus in Primary Total Hip Arthroplasty.

Authors:  Young-Soo Chun; Seung-Hyuk Lee; Sang-Hoon Lee; Yoon-Je Cho; Kee Hyung Rhyu
Journal:  Hip Pelvis       Date:  2014-09-29

5.  Epidemiology of Surgical Site Infections and Non-Surgical Infections in Neurosurgical Polish Patients-Substantial Changes in 2003⁻2017.

Authors:  Małgorzata Kołpa; Marta Wałaszek; Anna Różańska; Zdzisław Wolak; Jadwiga Wójkowska-Mach
Journal:  Int J Environ Res Public Health       Date:  2019-03-13       Impact factor: 3.390

Review 6.  Antimicrobial treatment options for neurosurgical ventricular shunt infections in children from 1993 to 2012: a systematic review.

Authors:  Richard J Drew; Theresa S Cole; Maggie K Lee; Stéphane Paulus; Conor L Mallucci; Andrew Riordan
Journal:  Childs Nerv Syst       Date:  2013-12-10       Impact factor: 1.475

7.  Transplant tourism complicated by life-threatening New Delhi metallo-β-lactamase-1 infection.

Authors:  Jenell Stewart; Gretchen Snoeyenbos Newman; Rupali Jain; Andrew Bryan; Heather Berger; Martin Montenovo; Ramasamy Bakthavatsalam; Catherine E Kling; Lena Sibulesky; Sherene Shalhub; Ajit P Limaye; Cynthia E Fisher; Robert M Rakita
Journal:  Am J Transplant       Date:  2018-10-29       Impact factor: 8.086

8.  Factors associated with postsurgical wound infections among breast cancer patients: A retrospective case-control record review.

Authors:  Rachel Zhao Fang Tan; Bernice Yong; Fazila Abu Bakar Aloweni; Violeta Lopez
Journal:  Int Wound J       Date:  2020-06-12       Impact factor: 3.315

9.  International Nosocomial Infection Control Consortium (INICC) national report on device-associated infection rates in 19 cities of Turkey, data summary for 2003-2012.

Authors:  Hakan Leblebicioglu; Nurettin Erben; Victor Daniel Rosenthal; Begüm Atasay; Ayse Erbay; Serhat Unal; Gunes Senol; Ayse Willke; Asu Özgültekin; Nilgün Altin; Mehmet Bakir; Oral Oncul; Gülden Ersöz; Davut Ozdemir; Ata Nevzat Yalcin; Halil Özdemir; Dinçer Yıldızdaş; Iftihar Koksal; Canan Aygun; Fatma Sirmatel; Alper Sener; Nazan Tuna; Özay Arikan Akan; Huseyin Turgut; A Pekcan Demiroz; Tanil Kendirli; Emine Alp; Cengiz Uzun; Sercan Ulusoy; Dilek Arman
Journal:  Ann Clin Microbiol Antimicrob       Date:  2014-11-18       Impact factor: 3.944

10.  Efficacy of a dual-ring wound protector for prevention of incisional surgical site infection after Whipple's procedure (pancreaticoduodenectomy) with preoperatively-placed intrabiliary stents: protocol for a randomised controlled trial.

Authors:  Alexsander K Bressan; Derek J Roberts; Janet P Edwards; Sana U Bhatti; Elijah Dixon; Francis R Sutherland; Oliver Bathe; Chad G Ball
Journal:  BMJ Open       Date:  2014-08-21       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.